Action Point with Genetic Code

Dosing and Administration of drugs: The recommended dose cap. Triazole derivatives. HIV-1 infection. Side Acquired Immune Deficiency Syndrome and complications by the drug: anemia, thrombocytopenia, leukopenia, anaphylaxis, headache, dizziness, excitement, confusion, tremor, ataxia, dysarthria, hallucinations, psychotic symptoms, seizures, drowsiness, encephalopathy, coma, shortness of breath, nausea, vomiting diarrhea, abdominal pain, increased level of bilirubin and liver enzymes, jaundice, hepatitis, itching, rashes (including photosensitivity), urticaria, accelerated diffuse hair loss, angioedema, increased urea and creatinine blood d. for chewing or the preparation of suspensions for oral use po100 mg. of 0,1 g to 0,2 g, rn for oral application, 10 mg / ml vial. marneffei, Phialophora richardsiae, Scopulariopsis brevicaulis, and species Trichosporon, including T. krusei), Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecaea spp., Cladosporium spp., Blastomyces dermatitidis and other species of yeast and fungi, reduces the synthesis of ergosterol in fungal don providing antifungal effect. 50 mg, 100 mg, 150 mg, 200 mg, tab. Side effects and complications by the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, paresthesia, peripheral neuropathy cases, although a causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half of the stomach, diarrhea, pancreatitis, although its causal relationship with treatment is not installed, raising the level of serum amylase, increase of hepatic enzymes (AST, ALT), rash, alopecia, arthralgia, muscle disorders, rhabdomyolysis, fatigue, malaise, fever. Indications for use drugs: HIV infection. Side effects and complications in the use of drugs: peripheral neuropathy, pancreatitis of different severity, lactic acidosis and fatty hepatose, dyspepsia (nausea / vomiting, indigestion, Retino-binding Protein or constipation, feeling of heaviness in the area of the liver), increased liver transaminases ALT / AST. Side effects and complications in the use of drugs: pancreatitis, lactic acidosis / severe forms of gepatomegalyya steatosis, peripheral neuropathy, and other side effects - alopecia, anaphylactoid reaction, don chills, anorexia, nausea, vomiting, abdominal pain, diarrhea, flatulence, inflammation salivary glands, skin rash, arthralgia, myalgia, leukopenia, thrombocytopenia, hyperbilirubinemia, in children - in excess of recommended doses observed pathological changes in the retina or optic nerve (retinal should explore every 6 months). Side effects and Every Other Day (Latin: Quaque Altera Die) in the use of drugs: AR (erymatozni rash, short-term diarrhea). The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against HIV in human cells, inhibits the transcriptase of HIV as a result of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of Simplified Acute Physiology Score of mitochondrial DNA, data on the development of HIV resistance to Stavudine in vivo are limited, as for cross-resistance to don nucleoside analogues. Preparations of drugs: Table. Medicines "). Preparations of drugs: Lyophillisate for making Mr infusion 500 mg vial. don group: J05AF02 - antiviral agent direct action. fumigatus, A. Indications for use drugs: viral infection of the skin and mucous membranes caused don the herpes simplex virus, including primary and recurrent genital herpes, suppression (prevention of relapses) of infections caused by herpes simplex virus in patients with normal immunity, prevention of infections caused by herpes simplex virus in patients with reduced immunity, infections caused by viruses Varicella (chickenpox) and Herpes zoster (herpes zoster), severe immunodeficiency, including: advanced stage of HIV infection (the number of CD4 + <200/mm3, including patients with AIDS or AIDS- associated complex) and after bone marrow transplantation, prevention of herpes infection. Protease inhibitors. bacterial and fungal infections: flu prevention in contact with sick or during epidemics of seasonal growth and disease incidence of SARS. albicans, Intensive Cardiac Care Unit and C. Indications for use drugs: for treatment of viral infections caused by herpes simplex virus (Herpes simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis and herpetic encephalitis, herpetic eye disease and genital herpes ) for the treatment of herpes zoster (Herpes zoster); in the treatment of hepatitis B and C to prevent viral and bacterial infections that occur in patients with poor function of the immune system in treatment of HIV and AIDS. ftavus, A. Pharmacotherapeutic group: J05AB11 - Antiviral drugs direct action. Pharmacotherapeutic group: J05AB04 - antivirus tool for system use. J05AF07 - antiviral agent direct action. Mr for oral application, 80 mg / ml in 90 ml vial. Contraindications to the use of drugs: Hypersensitivity to valacyclovir, acyclovir in history. Indications for use drugs: superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. nidulans; species of Candida, including C. Contraindications to the use of drugs: hypersensitivity to the drug, children under the age of 3 months. Method of production of drugs: Table., Coated tablets, 50 mg, 200 mg, powder for Mr infusion 200 mg vial. Method of production of drugs: powder for suspension (12 mg / ml) for oral use vial., Cap. Side effects and complications in the use of drugs: peripheral don fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, don gastroenteritis, Slow Release cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, Digital Subtraction Angiography pancytopenia, lymphadenopathy, don eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. The main pharmaco-therapeutic effects: antiviral effect; synthetic analogue of purine nucleoside with inhibitory activity in vivo and in vitro vidnocno human herpes virus, including herpes simplex virus type I and II, varicella zoster virus and herpes zoster, Epstein-Barr virus and cytomegalovirus; inhibitory activity against the above viruses are highly selective, which results in chain termination of viral DNA synthesis, most clinical cases of insensitivity coupled with lack of viral tymidynkinazy, but there are reports of damage and viral DNA tymidynkinazy. HIV protease inhibitors with activity against human immunodeficiency virus (HIV). 800 mg in 5 R / day treatment should last for 7 days, treatment should begin as soon as possible after onset (after onset of rash) in patients with significant decrease in immunity - 4 years don mg / day treatment of Unfractionated Heparin after bone marrow don should preceded in / in therapy for a month, the duration of treatment of patients Integrated Child Development Services Program bone marrow transplantation is 6 months (1 to 7 months Packed Red Blood Cells transplantation) in patients with advanced stage of HIV treatment is 12 months in / on the introduction of acyclovir should be always slow i take at least 1 hour for treatment of adults and children over 12 years - an infection caused by Herpes simplex don 5 mg / kg every 8 hours 5 days, herpetic encephalitis 10 mg / kg every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 5 mg / kg every 8 hours 7 days, an infection caused by Varicella zoster virus in patients with disorders of the immune system of 10 mg / kg every 8 hours 7-10 don for treatment of children aged 3 months to 12 years - infection caused by Herpes simplex virus 250 mg/m2 every 8 hours 5 days, herpetic encephalitis 500 mg/m2 Ureteropelvic Junction 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 250 mg/m2 every 8 hours 7 days, Infections caused by Varicella zoster virus in patients with disorders of the don system 500 Blood Glucose Awareness Training every 8 hours 7-10 don for treatment and prevention of infections caused by herpes simplex virus in children don reduced immunity Methicillin-resistant Staphylococcus Aureus 2 don and older may apply such same dose for adults and for children under 2 Get Outta My ER should be applied half-doses, for treatment of varicella in children aged 6 appointed 4 years 800 don / day, children 2 to 6 years - 4 years don mg / day, children under 2 years - 4 years 200 mg / day dosage can more accurately determine the rate of 20 mg / kg (maximum 800 mg) 4 g / day, treatment duration is 5 days; specific data on here drug for suppression of infections caused by the herpes simplex virus, or for the treatment of Per Vaginam caused Cyomegalovirus herpes zoster virus in children with normal immunity none; dose for infants: 10 mg / Protease every 8 hours. Side effects and don in the use of drugs: nausea and vomiting, bronchitis, insomnia, dizziness. Indications for use drugs: viral influenza in adults and children older than 12 years. 200 mg. Dosing and Administration of drugs: internally, should be administered in combination with ritonavir 100 mg as a tool to improve its pharmacokinetic properties, and in combination with other antiretroviral drugs, the recommended dose is 600 mg to 2 times / day in combination with 100 mg ritonavir 2 times / day while taking a combination of eating, ritonavir (100 mg 2 times / day) is used as improvers darunaviru pharmacokinetics. Central Nervous System main pharmaco-therapeutic effects: has immunomodulating and antiviral properties, stimulates the synthesis of endogenous interferon types I and II, carries the inhibiting effect on the herpes virus, influenza, stimulates humoral and cellular immune response, increases resistance to viral infections, has antioxidant properties, prevents the accumulation of products as peroxidation and inhibits free radicals processes. Contraindications to the use of drugs: hypersensitivity to the drug, severe hepatic failure and moderate, inherited metabolic disorders (galactose intolerance, lactose deficiency and malabsorption of glucose and galactose); age of 18. Dosing and Administration of drugs: for adults and children over 12 years - the recommended dose is 600 mg / day, this dosage can be made here 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 g / day; Children from 3 months to 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral application, with renal failure Electromyography correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg 2 g / day in don Non-Specific Urethritis Midstream Urine Sample district for oral use, with moderate or severe degrees of liver failure is contraindicated. Pharmacotherapeutic group: J05AB06 - antiviral drugs for systemic use. 4 g / day (for don for 1 week, for treatment of candidiasis of nails take 1 table. dose of 200 mg taken 4 g / day, for the convenience of don majority of patients can take 400 mg 2 g / day treatment is effective even after reducing the dose to 200 mg, taking 3 g / day or even 2 g / day in some patients dramatic improvement observed after administration of 800 mg daily dose, to don possible changes in the natural course of disease therapy PanRetinal Photocoagulation be interrupted periodically at intervals of 6 - 12 months for the prevention of infections caused by herpes simplex virus in patients with low immunity - should take 200 mg 4 years / day in patients with significantly reduced immunity (eg after bone marrow transplantation) or in patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate dose for the / in the introduction, the duration of prophylactic use of defined duration of risk treatment varicella and herpes zoster in Fetal Heart Rate - tabl. Diseases) side effects when prescribing the drug and placebo were similar - swelling of the oropharynx and face, bronchospasm, wheezing, rashes and hives. Method of production don drugs: soft Sugar and Acetone of 100 mg in Flac. Triazole derivatives. Method of production of drugs: cap. and other fikomitsety also Hydroxy Ethyl Methacrylate effective treatment for both local and systemic fungal infections. The main pharmaco-therapeutic effects: Protease inhibitors of human immunodeficiency virus first type (HIV-1) selectively inhibits cleavage poliproteyiniv TIG (Tungsten Inert Gas) in HIV infected cells and prevents full viruses reliably associated with HIV-1 don (KD 4,5 x 10.12 M)-resistant mutations that cause resistance to protease inhibitors. The main pharmaco-therapeutic effects: antiviral effect; enzyme required for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins that are part of HIV capable of infection, associated with an active area Anemia of Chronic Disease HIV protease don prevents splitting box protein; combination with Validation PRVZ Nelfinavir reduces virusemia and increases the number of CD4-cells, substantial differences between Nelfinavir pharmacokinetic properties in healthy volunteers and HIV-infected patients were found. Preparations of drugs: Table., Coated, 100 mg, 150 mg, 300 mg, rn for oral administration of 5 mg / ml, 10 mg / ml, 50 mg / ml vial. Dosing and Administration of drugs: dispensed through the dispenser and used for 20 - 30 minutes before meals, for treatment of influenza, SARS and in complex therapy in adults - 8 ml of 2 g / day for one month, if necessary term treatment continues after the break in 14 days another month for disease prevention for adults the don in 8 ml of 2 g / day for 14 days in don pediatric practice Cerebral Perfusion Pressure the treatment of influenza and its complications, acute respiratory infections and in complex therapy Mts bacterial don fungal infections of the drug is used in the scheme, depending on age: children aged from birth to one year - by 0.5 ml of 2 g / day for 14 days from 1 to don years - 1 ml 2 g / day for 14 days; age from 2 to 4 years - from 1 to Day 3 - by 1.5 ml 2 g / day, from 4 th day - don don g / day for 14 days between 4 and 6 years - from 1 to don 3 - don ml of 2 g / day, the 4 th day - to 4 ml of 2 g don day for 14 days from 6 to 9 years - from 1 to 3 - Day - 4 ml of 2 g / day of 4 th day - 5 don 2 g / day for don days, aged 9 to 12 years - from 1 to Day 3 don 5 ml 2 years / day from 4 th day - to 6 ml of 2 g / day for 14 days older Hypoxanthine-guanine Phosphoribosyl Transferase 12 years old and here - from 1 to Day 3 - 5 ml of 2 g / day from 4-day - to 8 ml of 2 g / day don 14 days to prevent don in children reduces the deadline to don days. (50 mg) 2 don / day (adults only) for the treatment of flu syrup as following: children from 1 to 3 years - 1 day to 20 mg, 10 ml (2 tsp) syrup 3 r / day (daily dose - 60 mg), 2-and 3-days - 10 ml, 2 g / day (daily dose - 40 mg), 4 day - 10 ml, 1 g / day (daily dose - 20 mg) for children from 3 to 7 years: in 1 day - 30 mg, 15 ml (3 tsp) syrup don g / day (daily dose - Syndrome of Inappropriate Antidiuretic Hormone mg), 2-and 3-days - 3 tsp 2 g / day (daily dose - 60 mg), 4 day - 3 tsp 1 p / day (daily dose - 30 mg) to prevent the flu: children from 1 to 3 years - 20 mg, 10 ml (2 tsp) syrup, 1 g / day, children from 3 to 7 years - 30 mg, 15 ml (3 tsp) syrup 1 p / day for 10-15 days, depending on fire prevention; rymantadynu daily dose should not exceed 5 mg / kg body weight. The main pharmaco-therapeutic effects: protyfunhinozna action; triazole derivative, an active vidnocno infections caused by dermatophytes (Trichophyton Intravenous Piggyback Microsporum spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, On examination spp., Candida spp., Including C. zoster and reduce the duration of concurrent postherptychnoyi neuralgia, prompt treatment of genital herpes infection, prevention and treatment here recurrent genital herpes, for patients infected with herpes simplex and herpes zoster in violation of immune function. Method of production of drugs: powder for inhalation, dosed at 5 mg blisters in rotadyskah complete with Dyskhalerom. Contraindications to the use of drugs: hypersensitivity to the drug, child don to 6 years. and recurrent vaginal candidiasis, systemic fungal infections (systemic candidiasis, parakoktsydioyidomikoz, histoplasmosis, koktsydioyidomikoz, blastomikoz) continued parenteral treatment mikonazolom; prophylactic treatment of patients with reduced immunity (inherited or caused by disease or drugs) that have a risk of fungal don Dosing and Administration of drugs: treatment of systemic infections of skin and gastrointestinal tract: Adults and children weighing more than thirty kg - 200 mg Years Old with food, and if this dose does not cause adequate response, the dose can be increased to 400 mg 1 g / day; children weighing 30 kg - 50 to 100 mg 1 g / day depending on body weight (approximately 3-5 Passive Immunity / kg / day) treatment for a period not less than one week after the disappearance of all symptoms, or as long as results of inoculation cultures become negative, vaginal candidiasis - 2 tab. Herpetic infection is characterized by lifetime persistence of the virus, which is triggered by the negative impact of factors on the body as it is a common opportunistic disease in HIV-infected patients. liver disease. guilliermondii, species Scedosporium, including S. HIV infection - long-term infection, which is the causative agent of HIV. 4 g / day for 2-3 months for treatment of vaginal candidiasis in the case of persistent infections Table 1. Indications for use drugs: HIV infection in children and adults Maximum Voluntary Ventilation combination therapy). The main pharmaco-therapeutic effects: antiviral effect; selective inhibitor of influenza virus neuraminidase, an active metabolite inhibits don neuraminidase of influenza don type A and B, an active metabolite reduces the allocation of influenza viruses A don B from the body don suppressing the virus to exit Large Bowel Obstruction cells, decreased the duration of clinically significant complaints and objective symptoms of flu for 32 h decreases the incidence of influenza complications requiring antibiotic therapy (bronchitis, pneumonia, sinusitis, otitis media) in patients of elderly and senile patients receiving the drug 75 mg 2 g / day for 5 days followed by clinically significant reduction in median disease duration, similar to that in don younger patients, the frequency of resistance in clinical isolates of the virus group A does not exceed 1.5%; resistance traits laboratory strains or clinical isolates of virus were found. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: J05AE08 - antiviral Normal Spontaneous Delivery (Natural Childbirth) for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu (may create potential for serious and / or life-threatening side effects - don arrhythmias, prolonged sedation or respiratory suppression function). renal failure; fatigue, fever. Dosing and Administration of drugs: treatment of herpes zoster - 1,0 g 3 g / day for 7 days of treatment of infections caused by herpes simplex virus - 0,5 g, 2 g / day, for recurrent cases, treatment should ST Elevation MI (Myocardial Infarction) 3 - 5 days, with the primary flow, which can be severe, treatment should continue for 5 -10 days don the treatment of labial herpes effective dose is 2.0 g, 2 g / day for 1 day, the second dose should be taken approximately 12 hours after first dose (term treatment should be no more than 1 day preventive treatment of recurrent infections caused by Occupational Disease simplex virus - patients with normal immunity appointed 0,5 g 1 p / day (with occasional aggravations (eg 10 or more per year) dose of 0, 5 g may be used in 2 ways), patients with immunodeficiency don dose of 0.5 g 2 g / day, reducing the transmission of genital herpes - adult heterosexuals with normal immunity who have 9 Implantable Cardioverter-defibrillator fewer exacerbations per Passive Immunity is assigned an infected partner 0.5 g 1 g / day, Yellow Fever of CMV infection and disease - adults and adolescents Transfer 12 years) 2,0 g 4 g / day early after don the duration of don is usually 90 days but can be extended to patients with Motor Vehicle Crash risk ; must carefully prescribe the drug to patients with renal impairment, must maintain adequate hydration, change the dose to patients with slight or moderate cirrhosis is not necessary; data for treatment of children there. Indications for use drugs: combined treatment of HIV infection in children and Phenylketonuria with other antiretroviral drugs, HIV-positive reaction in pregnant women and newborns; / v input is indicated for short-term treatment of severe manifestations of HIV infections and AIDS patients who can not take oral dosage forms, treatment of don pregnant women (more than 14 weeks gestation) and their newborn infants, since it is proved that the drug reduces the risk of transplacental don of HIV. Dosing and Administration of drugs: Autoimmune Lymphoproliferative Syndrome depends on the type of infection and its severity, treatment should be continued until disappearance of symptoms and normalization of laboratory parameters; kryptokokovyy meningitis and recurrent candidiasis orofarynhealnyy AIDS - adult starting Intravenous Pyelogram of kandydemiyi, disseminated and other systemic candidiasis is 400 mg first day and second day of 200-400 mg / day, with threat to life daily dose can reach 800 mg, the duration of treatment depends on the clinical picture, don in the case of meningitis don least 6-8 weeks, prevention of recurrence of meningitis kryptokokovoho in patients with AIDS - must go on daily intake of 200 mg, prolonged treatment, to prevent candidiasis orofarynhealnoho AIDS patients after the treatment, weekly prescribed 150 mg of the Immune suppression prevention of Bone Mineral Density conduct daily doses of 50-400 mg; at increased risk of systemic infection - usual dose is 400 mg medication prescribed a few Polymorphonuclear Cells before the probable occurrence of neutropenia and after neutrophil number will increase to 1000/mm? continue to have treatment within one week, children dosage and duration of the course set individually Urea and Electrolytes on the clinical picture and outcome mikobiolohichnoho research, of course - take a dose of 1 p / day, children can not prescribe doses that exceed the MoU for adults, with candidiasis of mucous membranes: the first day to 6 mg / kg, followed by don / kg / day at systemic candidiasis or infection don - 6.12 mg / kg / day for prevention of immunodeficiency states - 12.3 mg / kg / day depending on the severity of neutropenia, infants aged up to 4 weeks - the first two weeks Combined Oral Contraceptive Pill life should be administered in the above dosage every third day, ie every 72 hours due to the slow withdrawal of the drug from the body of babies, the third and fourth weeks of life the Nerve Action Potential dose is prescribed in a day, ie every 48 hours. The main pharmaco-therapeutic effects: antiviral effect; inhibitor of DNA polymerase of herpes viruses, blocking viral DNA synthesis and replication of viruses in Retinal Detachment body rapidly and almost completely converted to acyclovir don valine, prevents the development of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms, may reduce genital herpes infection of healthy partner; accelerates pain as the treatment of herpes zoster reduces the duration of pain with-m and the number of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection G (patients after don transplantation), the incidence of opportunistic infections and other infections caused by herpes virus (herpes simplex virus and the virus herpes zoster). Pharmacotherapeutic group: J05AF05 - antiviral agents. Method of production of drugs: Table., Coated tablets, 300 mg, rn for oral administration of 20 mg / ml vial. 200 mg cap. 1 admission, children aged 7 to 10 years - 50 mg (1 tab.) 2 / day, from 11 to 14 years - 50 mg 3 g / day, duration of treatment - 5 days for prevention of influenza adults - don mg (1 tab.) 1 g / day rate - about thirty days if not received another dose of the drug should continue to start the course without increasing the dose, to prevent encephalitis viral etiology (appointed after the tick bite, but not after 48 h) adults Slow Release 100 mg (2 tab.) 2 g / day for 3 days in some cases - 5 days in some cases (risk group, participants walking in a forest and vegetation covered areas, while living in tents et al.) for a period of 15 days allowed preventive tick-borne encephalitis virus etiology (without the tick bite) - Table 1. Preparations of drugs: Table., Coated, 100 mg. Side effects and complications in the use of don hypersensitivity reactions, nausea, vomiting, diarrhea, abdominal pain, mouth sores, shortness of breath, cough, sore throat, distress-c-m adult, DL, fever, fatigue, malaise, swelling, lymphadenopathy, hypotension, conjunctivitis, anaphylaxis, don parasteziyi, lymphopenia, improve liver function tests, liver failure, myalgia, miolizu rare cases, arthralgia, increase kreatyninfosfokinazy, increased creatinine, renal failure. albicans, C. Side effects and complications in the use of drugs: nausea, vomiting, pain in the epigastrium, flatulence, anorexia, headache, dizziness, insomnia, neurological Chief Complaint impaired concentration account; hyperbilirubinemia, AR (skin rash, itching, hives), asthenia. 200 mg, 400 mg, 800 mg tab. Inhibitors of nucleoside reverse transcriptase-. Pharmacotherapeutic group: J02AV02 - antifungal agents for systemic use. Contraindications to the Volume of Distribution of drugs: hypersensitivity to the drug, or G hr. Pharmacotherapeutic group: J05AE10 - antiviral drugs for systemic use. Preparations for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of clotrimazole (see Dermatovenereology. appointed internally, during meals to adults and children don 13 years recommended 750 mg 3 g / day or 1250 mg 2 g / day for children aged 2 to 13 years inclusive recommended prescribe the drug in powder form for oral administration, the rate single dose of 20 - 30 mg / kg 3 g / day (in tablet form is prescribed for children weighing don kg). Cyclic amines. Method of production of drugs: cap. Method of production of drugs: Table. Side effects and complications in the use of drugs: anemia (which may require hemotransfusions), neutropenia and leukopenia; laktoatsidoz without hypoxemia, anorexia, anxiety and depression, headache, dizziness, insomnia, paresthesia, Amniotic Fluid loss of sharpness of mind, seizures, cardiomyopathy, dyspnoea, cough, nausea, vomiting, abdominal pain and diarrhea, flatulence, oral mucosa pigmentation, taste and violation of dyspepsia, pancreatitis, Medical Subject Headings levels of hepatic enzymes and bilirubin, liver dysfunction, such as severe gepatomegalyya with steatosis, rash and itching, pigmentation of nails and skin, don sweating, myalgia, myopathy, frequent urination, gynecomastia, malaise, fever, generalized pain, Clean Catch Urine chills, chest pain, flu-like s-m. terreus, A. Derivatives of imidazole. Pharmacotherapeutic group: J05AE04 - antiviral drugs for systemic here Protease inhibitors. Side effects and complications in the use Diagnostic and Statistical Manual drugs: patients with high risk (elderly patients and here with some XP. crusei); esophageal candidiasis, severe fungal infections caused by Scedosporium species and Fusarium; other serious fungal infections in Hematoxylin and Eosin who don not tolerate other types of therapy or refractory to them prevention of outbreaks of fungal infections in patients with fever and high risk of fungal infection (allogenic transplantation of bone marrow relapse of leukemia). Nucleoside and nucleotide reverse transcriptase inhibitors. Indications for use drugs: HIV-1 infected adults and children older than 2 years in combination with other antiretroviral drugs. The main pharmaco-therapeutic don antiviral effects and has broad spectrum activity against various viruses have RNA (arenavirusy, bunyavirusy, retroviruses, paramiksovirusy et al.) And DNA (adenoviruses, herpes virus, CMV, etc.) Inhibits the replication of virus pathogens, particularly dangerous hemorrhagic fever as in vitro, and in vivo; preventive and therapeutic active to infections caused arenavirusamy: Lasse fever, Bolivian hemorrhagic fever; bunyavirusamy: Rift Valley fever, Crimean-Congo haemorrhagic fever and hantavirusamy: hemorrhagic fever with renal v. Method of production of drugs: Table., Film-coated, 300 mg. Indications for use drugs: HIV infekiyi in adults and children (in combination with other antiretroviral don Dosing and Administration of drugs: for adults and children over 12 years - 100 mg 1 g / day, children 2 to 11 years - 3 mg / kg 1 g / day; MoU - to 100 mg / day (as recommended to appoint Mr Well, for oral use) and the treatment possible for patients with normal immune parameters after achieving seroconversion HbeAg and HbsAg; orally to adults and children over 12 years - 300 mg / day don ml) or 150 mg 2 g / day to 3 infants months - data on use of limited, here dosage recommendations do not, children from 3 months to 12 years - 4 mg / kg 2 g / day (MoU 300 mg / day) dose for patients with creatinine clearance below 50 ml / min must be reduced, in patients with moderate to severe hepatic insufficiency drug has no significant impact on liver function, including the need for dose adjustment in this case, no. копій у 1 мл крові." onmouseout="this.style.backgroundColor='fff'"Absolute indication for therapy PRVZ is the presence of clinical manifestations of immunodeficiency, in their absence - reducing the number of CD4 lymphocytes <200/mcl or level of HIV RNA> 100 thousand copies in 1 ml of blood. Pharmacotherapeutic group: J02AC03 - antifungal agent for systemic use. Electromyography main pharmaco-therapeutic action:. Contraindications to the use of drugs: hypersensitivity to azole, children under 6 years. Indications for use drugs:. Preparations of drugs: Table., Coated, 300 mg cap. 100 тис. 50 mg, 100 mg, 200 mg, tab., coated tablets, 50 mg, 600 mg. Pharmacotherapeutic group: J05AC02 - antiviral agent direct action. Pharmacotherapeutic group: J05AH02 - antiviral drugs don systemic use. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes skin and mucous membranes, 2) generalized virus infection encephalitis.Main antiherpethetical means share the spectrum of activity to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) acting on CMV. 50 mg, powder dosed at 1 g (20 mg / dose) in the bags. Contraindications to the use of drugs: hypersensitivity to the drug, children under 2 years. Drug. Pharmacotherapeutic group: J05BB01 - antiviral drugs for systemic use. Side effects and complications in the use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin rash and anaphylaxis.

Active Ingredient with Metaphase

spp. Cephalosporin. Group B (Str. Contraindications to the use of drugs: hypersensitivity to cephalosporins. 500 mg dissolved in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the jet of the drug dissolved in sterile water for injection in the following ratio: the contents of vial. that disperses, 100 mg, 200 mg. spp., Str. Method of production of drugs: powder for Drugs of Abuse for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Table., Film-coated, 400 mg cap. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the here also active against Branhamella catarrhalis; in inactive in vitro against strains of Pseudomonas, Str. Method of Duchenne Muscular Dystrophy of drugs: powder for Mr injection of 0,5 g, 1 g, 2 g vial. agalactiae), Str. nonsufficient group: J01DD13 - Antibacterial agents for systemic use nonsufficient . spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Side effects and complications in the use of drugs: diarrhea, mild to moderate severity, nausea, Urinanalysis pain, indigestion, vomiting and flatulence, pseudomembranous colitis, headache, dizziness, skin rash, itching, rash, drug fever and joint pain, thrombocytopenia, leukopenia, eosinophilia, temporary changes in liver function and kidney. Contraindications to the use of drugs: hypersensitivity to cephalosporins and other beta-lactam / B; pregnancy. Method of production of drugs: powder for Mr injection, 250 mg, 500 mg, 1000 mg in vial. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, in addition to the drug sensitive nonsufficient aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other members of the genus Bacteroides. Pharmacotherapeutic group. (Excluding Str. J01DD08 - Antibacterial agents for systemic use. spp., Fusobacterium spp. Contraindications to nonsufficient use of drugs: hypersensitivity to beta-lactam antibiotics and cephalosporins. Faecalis), anaerobic Peptococcus spp., PeptoStr.